– USA, CA – Medable Inc., the leading SaaS platform for patient-centered clinical trials, today announced the appointment of Mike Kourey to its board of directors, bringing unparalleled expertise in scaling both public and private enterprise software companies.
“The Medable SaaS platform enables leading life sciences companies to drive adoption of decentralized clinical trials at an enterprise level. As a member of Medable’s board of directors, Mike’s know-how in developing scaled SaaS companies will be invaluable as we look to further empower our partners and deliver unsurpassed customer and patient success around the world,” said CEO and co-founder, Dr. Michelle Longmire.
About Mike Kourey
In his more than 25 years of experience, Mike Kourey has had a significant track record in helping hyper-growth companies scale. He shepherded five successful IPOs as CFO, venture partner, or audit chair, including Okta, RingCentral, Aruba Networks, Riverbed, and Polycom. Kourey was also CFO of Vlocity when it was acquired by Salesforce. This depth of experience will drive tremendous value for Medable’s stakeholders, and most importantly, patients worldwide.
“Medable is changing the game when it comes to clinical trials and drug development – focusing on equitable, patient-first decentralized and hybrid studies designed to measure the true impact of therapies in real-world settings,” commented Mike Kourey. “I am thrilled to join Michelle and Medable’s brilliant team of powerhouse leaders as they drive Medable to unprecedented heights in the health tech industry.”
As CFO of Dialpad, Kourey leads finance, accounting, corporate development, investor relations, IT, sales operations, and facilities. Before Dialpad, he served as the CFO of Okta after five years as a board member and audit committee chair. Previously, Kourey was CFO for software company Vlocity, now part of Salesforce, and CFO for customer experience management company Medallia. He also was a partner at Khosla Ventures.
Kourey is currently a board member and audit committee chair at both Illumio and Invision and has served on the boards and audit committees of Aruba Networks, RingCentral, and Riverbed.
He holds an MBA from Santa Clara University and a bachelor’s degree from the University of California, Davis.
About Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention, and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. Medable connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Medable is a privately held, venture-backed company headquartered in Palo Alto, California.
For more information: https://www.medable.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
